Virological, weight, and drug resistance outcomes among patients initiating a dolutegravir-based first-line antiretroviral therapy regimen in Zimbabwe

Vinie Kouamou,Tendai Washaya,Tichaona Mapangisana,Chiratidzo Ellen Ndhlovu,Justen Manasa
DOI: https://doi.org/10.1097/qad.0000000000003830
IF: 4.632
2024-03-15
AIDS
Abstract:Dolutegravir (DTG)-based antiretroviral therapy (ART) is being scaled up in Africa. However, clinical experience with DTG and patterns of HIV drug resistance (HIVDR) are sparse in Zimbabwe. We assessed virological, weight, and HIVDR outcomes among individuals initiating on a DTG-based ART.
immunology,infectious diseases,virology
What problem does this paper attempt to address?